WADA 2026: Testing Volume Rises, Growth Decelerates, and a Financial Fault Line Opens Beneath Anti-Doping

WADA 2026: Testing Volume Rises, Growth Decelerates, and a Financial Fault Line Opens Beneath Anti-Doping

The moment nobody films

On a late November morning in 2026, at a training pool in Ho Chi Minh City, a sample collection officer from Vietnam's Anti-Doping Centre knocked on a changing-room door. The athlete signed the form, completed the whereabouts information, provided the sample. Forty minutes. No spectators, no cameras, no applause.

Four months later, the World Anti-Doping Agency — WADA — published its 2026 annual report. Global sample volume for 2026 reached 297,965 tests, up roughly 9,100 from 288,865 in 2026.

Read the headline and you picture an upward curve. When I rebuilt the 2026–2026 series, the curve still rises but its slope has been filed down: growth of 12.5% in 2026–2026 shrank to 3.2% in 2026–2026.

I once believed that if absolute numbers rise, the system is healthy. Eighteen years of writing about how the body moves taught me otherwise: in physiology, the rate of deceleration matters more than the absolute value. WADA's problem today is not how many samples exist. It is how much longer the system can keep accelerating.

Every injury is a story the body is trying to tell us. Every WADA annual report is the same — it tells a story leadership often does not want to hear in full.

Context: a three-tier system and a country on tier three

To read this report correctly, you have to understand the three tiers.

Tier one is WADA — the global regulator that drafts the World Anti-Doping Code, monitors compliance and coordinates resources. Tier two is the international federations, among them World Aquatics, which governs swimming, diving, artistic swimming and open water. Tier three is the national anti-doping organisations — in Vietnam, the Anti-Doping Centre under the General Department of Sports and Physical Training.

The WADA 2026 data sits mostly on tiers one and two. But the consequences fall on tier three — where a collection officer in District 7 has to decide whose door to knock on today.

Based on my experience following matches and major Games, swimming is among the highest resource consumers in the Olympic testing system. The reason is concrete: a swimmer can race five to seven events at a single meet, each with heats, semi-finals and finals. More race appearances mean more in-competition testing windows. Add year-round out-of-competition requirements, and the cost of monitoring one swimmer runs well above that of a single-event athlete.

That makes swimming the most sensitive sport to any shift in global testing budgets. When WADA adds samples, swimming benefits. When WADA runs short of money, swimming feels it first.

The 2026 report shows both happening at once.

Curve one — testing volume is losing momentum

Across seven years, 2026 to 2026, the picture is an almost unbroken rise. But split the two most recent periods and a detail emerges.

2026–2026: testing volume up 12.5%. 2026–2026: testing volume up 3.2%.

Total samples 2026: 288,865. Total samples 2026: 297,965.

Absolute difference: about 9,100 samples.

In sports medicine I still use one rule when reading an athlete's recovery data: don't look at the peak, look at the derivative. An athlete may still be running faster than last week, but if the improvement rate falls from 8% to 2%, the body is signalling a limit. Training literature calls this deceleration of improvement, and it usually appears before injury erupts.

WADA's testing curve is in exactly that state.

There are three explanations, and the public data cannot choose among them.

First, the system has hit its operational ceiling: the supply of collection officers, accredited laboratories and travel capacity has reached its limit. Adding another 12% would require more money and more people — precisely what the financial section shows is missing.

Second, WADA leadership has deliberately shifted from broad routine testing to targeted investigation. The report itself hints at this when it describes a move "from predominantly traditional athlete drug testing to investigations and prevention efforts."

Third, part of the resource base is being absorbed by major investigations — more than 250 operations, 88 laboratories dismantled, over 90 tonnes seized. Investigation consumes people and time, and it produces no samples.

All three explanations converge on one conclusion: the slowdown in testing-volume growth is not a sign that the system has lost the will, but that it has changed how it spends. The problem is that when spending changes, a sport like swimming can be pushed to the margins.

Curve two — the AAF rate is flat, and that is a rare piece of good news

AAF stands for Adverse Analytical Finding — the technical name for a positive sample.

Three years in a row, the rate barely moved:

2026: 0.77%. 2026: 0.80%. 2026: 0.78%.

The band of variation is only 0.03 percentage points.

For anyone who works with data, this is the most robust finding in the whole report. An indicator that stays inside a narrow band for three straight years is trustworthy. It is not noise.

There are two readings.

The positive one: a stable detection rate means test quality has not degraded. If laboratories weakened, detection would fall. It has not.

The cautious one: a stable detection rate while sample volume rises can mean two opposite things. Either real abuse prevalence in the athlete population is flat. Or the system is targeting smarter — selecting the right people — so that even broader screening returns a similar rate.

The public data cannot separate these. This is where I have to remind myself of an old principle: data is a pile of dry bones; context is what turns it into blood vessels.

The context here: a rate of 0.78% means roughly one positive sample in every 128. Across 297,965 samples in 2026, that converts to roughly 2,300 AAF cases worldwide. That number names no athlete, no sport, no country. It says only that the boundary between clean and dirty sport is being held at a stable level — not worsening, not improving.

Curve three — non-conformity is rising exactly where it is most dangerous

This is the section I want to spend the most time on, because it is the one headlines skip most often.

WADA conducts compliance audits. In the reporting period, nine audits were carried out.

The average number of non-conformities per audit fell from 25.5 to 20. Superficially, that is progress.

Split by type, the picture reverses.

Non-conformities related to testing procedure accounted for 45% of all findings, up 11% year on year, and 23% of those were classified as critical.

In other words: the system is doing better in the boxes that are easy to fix, and worse in the one box that is hardest — sample collection.

For someone in my line of work, decoding injuries, this is a familiar pattern. When an athlete recovers well on static tests but the pain returns during dynamic testing, the problem is not strength but motor control. The same applies here. National anti-doping organisations can file every document, every procedure, every report — but if on-site collection is not up to standard, the whole system loses its value.

A sample taken at the wrong time, in the wrong volume, under the wrong storage conditions, or with the wrong paperwork is a sample that cannot support a conclusion. Legally, it is close to worthless. Biologically, it can lead to a wrong conclusion in either direction: missing a genuine positive, or branding an innocent athlete.

I have to be explicit about the limits of this data: there were only nine audits. With a sample that small, a fall from 25.5 to 20 is not enough to establish a durable improvement trend. If the composition of the nine audited bodies changed between years, the comparison is weaker still.

But the 45% share and the 11% rise are directional numbers. They point to pressure landing on national anti-doping organisations — the least-resourced group in the three-tier system.

And this is where I have to put myself in the shoes of the people involved. Before criticising a national organisation for falling short, try imagining an officer managing hundreds of athletes across a whole country, with one vehicle, one sample kit and a budget that does not grow. Failing to complete every form is not laziness. It is the output of a resource equation.

Curve four — cash flow and the crack at the top tier

This is the heaviest part of the report.

WADA's budget came in 8.3 million US dollars below plan.

The two largest shortfalls have names:

The United States is behind on 3.8 million US dollars.

Russia is behind on 3.9 million US dollars.

Together, these two account for most of the shortfall.

On the other side, WADA recorded a net surplus of 1.2 million US dollars.

This is where I stopped longest, because it contains a paradox.

An organisation that posts a net surplus while running a budget shortfall of 8.3 million dollars can only be in one of two states. Either it has cut spending hard to keep the books balanced — meaning some testing, investigation or national-support costs were deferred. Or revenue arrived but was committed to activities outside the original forecast.

Both possibilities lead to the same risk: resources for field testing get squeezed in the period ahead.

I once wrote about the transfer market that injury is the interruption everyone pretends not to hear. In this story, the 7.7 million dollars owed by two countries plays the same role. It is not loud, but it sits there, and it changes every calculation behind it.

What is striking from a governance standpoint is the revenue structure. WADA takes money from the International Olympic Committee and from national governments. That means the body with the power to sanction non-compliant countries depends financially on those very countries. In any system, having the lawmaker live on the money of the law's subjects is a structural weakness.

And when arrears stretch across multiple periods, something worse happens: they become precedent. A country that sees another delay without serious consequence will reconsider paying on time.

The fifth axis — the pivot to investigation

The least discussed but strategically heaviest part of the report is the shift in focus.

WADA describes a new direction: from traditional testing to investigation and prevention.

The accompanying numbers:

More than 250 investigation operations. 88 laboratories producing prohibited substances dismantled. Over 90 tonnes of materials and products seized.

These results cannot be achieved by adding urine samples. You do not dismantle a laboratory by collecting at a pool. You do it through criminal investigation, information-sharing with law enforcement and control of the raw-material supply chain.

Conceptually, this is a sensible move. Testing is a tool for detecting behaviour after it happens. Investigation is a tool for stopping behaviour before it happens. In anti-doping, prevention is always cheaper than detection.

But there is a consequence the report does not spell out.

Investigation does not generate public data the way testing does. A successful investigation usually ends in administrative or criminal sanction, not in a neatly comparable line of data. That means as WADA shifts resources toward investigation, the system's measurable effectiveness via public data will decline.

For a writer, this is a genuine challenge. In the coming years I may have to accept that slower testing growth does not mean the system is weakening — only that it is fighting on a different front, one with no scoreboard.

The 2027 Code: the date is known, the readiness is not

The anchor with the highest planning value in the whole report is the 2027 edition of the World Anti-Doping Code.

The Code was adopted in Busan, South Korea.

Effective date: 1 January 2027.

For any national federation, that is a fixed, reverse-plannable milestone. You know exactly how many months remain to update procedures, train staff, revise forms and synchronise data systems.

But the window between now and then is also a risk window. During transition, organisations still operate to the old standard while the new one is already published. Bodies that adapt slowly will enter 2027 with a compliance gap.

Procedurally, the 2027 edition is a code whose drafting is complete but whose enforcement has not begun. That distinction matters when reading the news: adoption does not mean enforcement. Between those two markers lies all the preparation work — and all the risk.

An underrated bright spot: the athlete voice

WADA and the Athlete Council ran an athlete-centred consultation process.

Scale: more than 600 athletes and commission representatives, spanning more than 60 countries and more than 70 sports.

This is one of the few indicators in the report that reflects the interests of the people who actually train.

One thing must be said plainly, because the data does not answer it: the report offers no measure of whether athlete input actually changed the substance of the Code. The number of people consulted is an indicator of process, not of outcome. A consultation that asks 600 people and absorbs nothing can still present the number 600 very attractively.

In the long run, though, the maturation of athlete-representation bodies matters. In systems where athletes have a collective voice, procedural protections in doping cases tend to be tighter. That is a trend I will be watching over the next few years.

Vietnamese swimming seen through this report

One thing must be stated immediately: the WADA 2026 report is a cross-sport governance document. It contains no swimming-specific data, names no swimmer, analyses no stroke technique and evaluates no event.

Which means any conclusion of the form "Vietnamese swimming is at risk level X" would be an inference beyond the data. I will not make it.

What can be discussed is structure. And structure has consequences.

Vietnam sits on tier three. Sports like swimming are high consumers of testing resources. Vietnam's Anti-Doping Centre must operate under the current Code, prepare for the 2027 Code, and manage a workload spanning in-competition testing at domestic events, out-of-competition testing, and regional Games such as the SEA Games, the ASIAD and continental championships.

From what I understand of how Vietnamese sport operates, a swimmer at national-team level must keep whereabouts information current, be available for no-notice out-of-competition testing, and file medical documentation for every medication used in treatment. These are administrative obligations that are far from light for an athlete training twice a day.

When the report shows testing-stage non-conformity up 11% globally, I have no evidence to claim that this happens in Vietnam. But I have enough experience to say that a national anti-doping organisation facing a squeezed budget, asked to do more with less, and required to prepare for a new code is an organisation under double pressure.

And I also have enough experience from my own mistakes not to jump to conclusions.

The counter-intuitive angle: the headline says "up", the data says "slower"

This is the point I want people to carry away.

The press release headline says WADA is increasing sample collection.

The data show the increase is decelerating: from 12.5% to 3.2%.

The headline suggests a system flexing its strength.

The data show a system changing direction, tightening up and dealing with lost revenue.

That gap is not a lie. It is the product of a widespread communications convention: pick the most positive element of a neutral dataset and put it on top.

I once believed that if an agency published full data, the headline would take care of itself. I was wrong. Full data does not automatically produce an honest headline. It only creates the conditions for a reader to check — if they have the time and the method.

Most sports readers do not have time to rebuild a data series. So the responsibility does not rest with them.

One more thing deserves naming. The same report contains two opinion statements from its own authors: one calls the outcome a win for WADA, another says the figures suggest a growing struggle with testing. Those two sentences sit side by side in one document. That is a sign that even the people compiling the report have not settled the story.

For a general reader, the safest approach is to hold to the verifiable data series and to mark clearly what is fact and what is interpretation.

Signals to watch over the next 12 months

I keep a short list for myself, and for readers to follow along.

One: the rate of testing-volume growth in the next report. If growth falls to zero or turns negative, that is a sign of operational capacity erosion, not strategic redirection.

Two: the AAF rate. It currently sits near 0.78%. If it breaks above 0.85%, questions arise about targeting methods or about actual abuse prevalence.

Three: the testing-stage non-conformity share, currently 45%. If it keeps rising, this is a systemic problem of national organisations, not a problem of athletes.

Four: payment status on the two big arrears. If they are settled, pressure on testing eases. If they persist, WADA's funding model faces a sustainability question.

Five: readiness for the 2027 Code among national organisations. This can be observed through official announcements and transition plans.

What I learned from reading a governance report

My trade is reading athletes' bodies through data. But one principle applies to both bodies and institutions: the pain is not always where you see it.

In a hamstring tear, the pain is usually at the back of the thigh, but the original weakness may sit in the glutes or in pelvic control. Treating and testing the painful site while ignoring the original weakness is the most common route to re-injury.

In the anti-doping system, the visible pain is the detection rate. But the original weakness may sit in cash flow, in sample collection in under-resourced countries, and in the gap between the day a code is adopted and the day it takes effect.

I once misread a public medical report about a striker's thigh injury, predicting two weeks when the reality was two months. That mistake taught me that public documents are the beginning of a question, not the end of an answer.

The WADA 2026 report is the same. It gives me a seven-year testing series, a stable detection rate, a worrying compliance cross-section, a financial statement with holes, a strategic pivot, and one fixed date.

The rest is blank space that only future reports can fill.

Glossary of terms used here

WADA — the World Anti-Doping Agency, which coordinates global anti-doping rules and standards.

AAF (Adverse Analytical Finding) — the technical term for a sample positive for a prohibited substance or method.

World Anti-Doping Code — the core document harmonising anti-doping rules worldwide. The 2027 edition is the upcoming version.

Non-conformity — a finding that an anti-doping organisation or government fails to meet the Code or International Standards.

Athlete Biological Passport — a long-term tool tracking an athlete's physiological markers over time.

Out-of-competition testing — no-notice testing conducted outside competition periods.

Compliance audit — a WADA review assessing whether a signatory meets Code requirements.

An open ending

There is a line I have carried for years from writing about VAR: before blaming VAR, ask why we need it. In this story, the equivalent question is: before demanding that WADA test more, ask who is paying for each sample.

If the 7.7 million dollars in arrears from the United States and Russia continues, we may see one of two scenarios in the coming years. One: WADA tests less but investigates more, and swimming — with its high resource consumption — feels the change first. Two: the system holds testing volume steady while collection quality in under-resourced countries keeps eroding, and the credibility of the whole system is staked on weaknesses at tier three.

Neither scenario appears in a headline.

For Vietnamese swimming, the task over the next 18 months is to prepare for the 2027 Code now, not in 2027. For fans, the task is to remember that a properly collected urine sample at a pool in Ho Chi Minh City and a properly collected sample at a pool in Budapest depend on the same cash flow, the same procedure set and the same audit chain.

And when that cash flow cracks, the crack does not appear where the audience sits.